AGENDA for the MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
October 25-26, 2011

Centers for Disease Control and Prevention

Location: 1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Atlanta, Georgia

PURPOSE

PRESIDER/PRESENTER(s)

AGENDA ITEM

Tuesday, October 25, 2011

8:00

Dr. Carol Baker (ACIP Chair)

Welcome & Introductions

Dr. Larry Pickering (ACIP Executive Secretary; CDC)

8:30

Human Papillomavirus Vaccine

Dr. Joe Bocchini (ACIP, WG Chair)

· Introduction 

Ms. Julianne Gee (CDC/NCEZID)

· Post licensure safety studies 

Information & 
Discussion

Dr. Christine Velicer, Merck

· Manufacturer safety study 

Dr. Lauri Markowitz (CDC/NCHHSTP)

· Background Information – HPV vaccine for males 

Vote

Dr. Eileen Dunne (CDC/NCHHSTP)

· GRADE (Grading of Evidence) and proposed recommendation 
for males

10:30

Break

11:00

Vote

Dr. Eileen Dunne (CDC/NCHHSTP)

· Proposed catch-up recommendation for males 

VFC Vote

Dr. Jeanne Santoli (CDC/NCIRD)

· VFC vote

11:30

Child/Adolescent Immunization Schedule

Dr. Cody Meissner (ACIP, WG Chair)

· Introduction

Vote

Dr. Iyabode Beysolow (CDC/NCIRD)

· 2012 immunization schedule 0-18 years of age

12:00

Adult Immunization Schedule

Ms. Kris Ehresmann (ACIP, WG Chair)

· Introduction 

Vote

Dr. Carolyn B. Bridges (CDC/NCIRD)

· 2012 adult immunization schedule

12:30

Lunch

1:45

Hepatitis B Vaccine

Dr. Mark Sawyer (ACIP, WG Chair)

· Introduction

Dr. Sarah Schillie (CDC/NCHHSTP)

· HBV risk among adults with diabetes

Information & 
Discussion

Dr. Trudy Murphy (CDC/NCHHSTP)

· Summary of considerations

Dr. Pamela Allweiss (CDC/NCCDPHP)

· Assisted blood glucose monitoring

Dr. Kathy Byrd (CDC/NCHHSTP)

· Implementation/vaccine coverage

Dr. Sarah Schillie (CDC/NCHHSTP)

· GRADE (grading of evidence)

Vote

Dr. Trudy Murphy (CDC/NCHHSTP)

· Proposed recommendations

3:45

Break

4:00

Meningococcal Vaccines

Dr. Amanda Cohn (CDC/NCIRD)

· Introduction

Ms. Jessica MacNeil (CDC/NCIRD)

Information & 
Discussion

· Epidemiology of meningococcal disease in infants

Dr. Ismael Ortega-Sanchez (CDC/NCIRD)

· Cost effectiveness considerations for meningococcal vaccines in 
infants

Dr. Amanda Cohn (CDC/NCIRD)

· Considerations for use of meningococcal vaccines in infants

5:30

Public Engagement

Information & 
Discussion

Dr.Glen Nowak (CDC/NCIRD)

· Summary of public engagement for meningococcal vaccines in 
infants

5:45

Public Comment

6:00

Adjourn




Wednesday, October 26, 2011

8:00

Dr. Carol Baker (Chair, ACIP)

Unfinished Business

8:15

Agency Updates

Information

Ex officio members

CDC, CMS, DoD, DVA, FDA, HRSA, IHS, NVPO, NIH

8:30

13-valent Pneumococcal Conjugate Vaccine (PCV13)

Dr. Mike Marcy (ACIP, WG Chair)

· Introduction

Dr. Peter Paradiso (Pfizer)

· Immunogenicity of PCV13 in adults: results of phase III studies

Information & 
Discussion 

Dr. Kathleen Dooling (CDC/NCIRD)

· Considerations for PCV13 use among adults with 
immunocompromising conditions: summary of immunogenicity 
and efficacy studies

9:30

General Recommendations/Febrile Seizures

Information & 
Discussion 

Dr. Jeff Duchin (ACIP, WG Chair) 
Dr. Andrew Kroger (CDC/NCIRD)

· Update on febrile seizures and vaccines

9:40

Pertussis

Dr. Mark Sawyer (ACIP, WG Chair)

Information

· Update: FDA expanded age indication for Tdap (Boostrix)

Dr. Mark Sawyer (ACIP, WG Chair)

· Update: pertussis vaccines workgroup activities

 

9:50

Information

Dr. Lance Rodewald (CDC/NCIRD)

Immunization coverage of children/adolescents

10:00

Information

Dr. Jeanne Santoli (CDC/NCIRD)

Vaccine Supply

10:10

Break

10:30

Measles

· Introduction

Dr. Jon Temte (ACIP, WG Chair)

Dr. Huong McLean (CDC/NCIRD)

· Epidemiology of measles in the United States

Information 
& 
Discussion

Dr. Gaston de Serres (Institut national de santé 
publique du Québec)

· Measles outbreak in Canada

Dr. Vesta Richardson (ACIP, NICCHP)

· Measles prevention activities in Mexico

Dr. George Siberry (NIH)

· Measles vaccination among children with HIV infection

Dr. Huong McLean (CDC/NCIRD)

· Summary of options

12:15

Influenza

Dr. Wendy Keitel (ACIP, WG Chair)

· Introduction

Dr. Lisa Grohskopf (CDC/NCIRD)

· Influenza activity update

Information 
& 
Discussion

Dr. Mark Thompson (CDC/NCIRD)

· Vaccine effectiveness

Dr. Pedro Moro (CDC/NCIRD)

· Fluzone high-dose safety update

Dr. James Singleton (CDC/NCIRD)

· Influenza vaccine distribution and coverage

1:00

Public Comment

1:15

Adjourn

Acronyms

GRADE

Grading of Recommendations Assessment, Development and Evaluation

NACI

National Advisory Committee on Immunization, Canada

NCCDPHP

National Center for Chronic Disease Prevention and Health Promotion

NCEZID

National Center for Emerging and Zoonotic Infectious Diseases

NCHHSTP

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 

NCIRD

National Center for Immunization and Respiratory Diseases

NICCHP

National Immunization Council and Child Health Program, Mexico

TBD

To be determined

Tdap

Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine

WG

Work Group